James Langabeer is internationally recognized for quality and outcomes research in emergency medicine and public health. He is a tenured full professor with joint appointments at the McGovern Medical School (Emergency Medicine), UT School of Public Health (Health Management and Policy), and the School of Biomedical Informatics. His research focuses on emergency, cardiovascular, and addiction medicine. Dr. Langabeer is a Fellow of the American Heart Association and the American College of Healthcare Executives.
Dr. Langabeer currently leads a national clinical trial for opioid use disorder, called the Houston Emergency Opioid Engagement System (HEROES).
He is the Associate Editor for Western Journal of Emergency Medicine and the national Chair of the American Heart Association’s Ambulatory Quality committee.
Emergency Cardiovascular Care, Substance Use Disorders, Emergency Medical Systems (EMS)
Population Health, Opioids, Telemedicine
Dr. Langabeer currently leads one of the largest emergency-based opioid programs in the country (HEROES). He has been funded by multiple federal and state agencies, including HHSC, CDC, and the AHA. His research has been published in nearly 100 journal articles, including Annals of Emergency Medicine, Pediatrics, Substance Abuse, and the Journal of American Heart Association.